Cargando…

Pathogen detection in the CRISPR–Cas era

CRISPR–Cas systems have provided revolutionary tools for genome editing. The discovery of Cas proteins with alternative activities has now enabled sensitive and robust tools for detecting nucleic acids. Recent reports harnessing these new CRISPR–Cas technologies display their potential for providing...

Descripción completa

Detalles Bibliográficos
Autor principal:	Sashital, Dipali G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937823/ https://www.ncbi.nlm.nih.gov/pubmed/29690921 http://dx.doi.org/10.1186/s13073-018-0543-4

Ejemplares similares

The Cas4-Cas1-Cas2 complex mediates precise prespacer processing during CRISPR adaptation
por: Lee, Hayun, et al.
Publicado: (2019)

Cas4/1 dual nuclease activities enable prespacer maturation and directional integration in a type I-G CRISPR-Cas system
por: Dhingra, Yukti, et al.
Publicado: (2023)

Cas4/1 dual nuclease activities enable prespacer maturation and directional integration in a type I-G CRISPR-Cas system
por: Dhingra, Yukti, et al.
Publicado: (2023)

CRISPR-Cas effector specificity and cleavage site determine phage escape outcomes
por: Schelling, Michael A., et al.
Publicado: (2023)

Systematic in vitro specificity profiling reveals nicking defects in natural and engineered CRISPR–Cas9 variants
por: Murugan, Karthik, et al.
Publicado: (2021)

Cas9 immunity creates challenges for CRISPR gene editing therapies
por: Crudele, Julie M., et al.
Publicado: (2018)

CRISPR/Cas9 can mediate high-efficiency off-target mutations in mice in vivo
por: Aryal, Neeraj K, et al.
Publicado: (2018)

High-frequency random DNA insertions upon co-delivery of CRISPR-Cas9 ribonucleoprotein and selectable marker plasmid in rice
por: Banakar, Raviraj, et al.
Publicado: (2019)

Knocking out consumer concerns and regulator’s rules: efficient use of CRISPR/Cas ribonucleoprotein complexes for genome editing in cereals
por: Wolter, Felix, et al.
Publicado: (2017)

CRISPR interference and priming varies with individual spacer sequences
por: Xue, Chaoyou, et al.
Publicado: (2015)

Comment on Tanmoy et al. CRISPR-Cas Diversity in Clinical Salmonella enterica Serovar Typhi Isolates from South Asian Countries. Genes 2020, 11, 1365
por: Fabre, Laetitia, et al.
Publicado: (2021)

Application of the CRISPR/Cas System in Pathogen Detection: A Review
por: Yuan, Bowei, et al.
Publicado: (2022)

An adaptable defense
por: Schelling, Michael A, et al.
Publicado: (2020)

Open questions: CRISPR biology
por: Koonin, Eugene V.
Publicado: (2018)

Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods
por: Wang, Xinjie, et al.
Publicado: (2020)

Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens
por: GAO, Hongdan, et al.
Publicado: (2022)

Advancements in the synergy of isothermal amplification and CRISPR-cas technologies for pathogen detection
por: Mao, Xiaolei, et al.
Publicado: (2023)

CRISPR-based assays for low-resource settings
por: Huang, Zhen, et al.
Publicado: (2023)

A new era in solar system astronomy with JWST
por: Villanueva, G. L., et al.
Publicado: (2023)

CRISPR-Cas systems: ushering in the new genome editing era
por: Perez Rojo, Fernando, et al.
Publicado: (2018)

CRISPR-Cas technology a new era in genomic engineering
por: Parsaeimehr, Ali, et al.
Publicado: (2022)

Diagnosis of EVALI in the COVID-19 era
por: Kazachkov, Mikhail, et al.
Publicado: (2020)

CRISPR-Cas13: A new technology for the rapid detection of pathogenic microorganisms
por: Huang, Zhanchao, et al.
Publicado: (2022)

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid
por: Li, Xiaoping, et al.
Publicado: (2023)

Computational thinking in the era of big data biology
por: Schatz, Michael C
Publicado: (2012)

Natural human knockouts and the era of genotype to phenotype
por: Alkuraya, Fowzan S
Publicado: (2015)

Offline: Science and politics in the era of COVID-19
por: Horton, Richard
Publicado: (2020)

Participant stress in the COVID-19 era and beyond
por: Goldfarb, Elizabeth V.
Publicado: (2020)

Infectious diseases in China in the post-SARS era
por: Gibney, Katherine B, et al.
Publicado: (2017)

Managing supply chain resilience in the era of VUCA
por: Gao, Ying, et al.
Publicado: (2021)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
por: Nicol, Dianne, et al.
Publicado: (2017)

Protecting trust in medical genetics in the new era of forensics
por: Curtis, Caitlin, et al.
Publicado: (2018)

Management of mother–newborn dyads in the COVID-19 era
por: Medvedev, Melissa M
Publicado: (2020)

Bringing research directly to families in the era of COVID-19
por: Balevic, Stephen J., et al.
Publicado: (2020)

Challenges and opportunities to end tuberculosis in the COVID-19 era
por: Wingfield, Tom, et al.
Publicado: (2021)

Virulence of the Pathogen Porphyromonas gingivalis Is Controlled by the CRISPR-Cas Protein Cas3
por: Solbiati, Jose, et al.
Publicado: (2020)

Mucin induces CRISPR-Cas defense in an opportunistic pathogen
por: de Freitas Almeida, Gabriel Magno, et al.
Publicado: (2022)

CRISPR/Cas-Based Biosensor As a New Age Detection Method for Pathogenic Bacteria
por: Chakraborty, Joydeep, et al.
Publicado: (2022)

CRISPR-Cas-based techniques for pathogen detection: Retrospect, recent advances, and future perspectives
por: Huang, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1r1cc2u906ntvmjqrt7rqkoq1p